In MCF-7 human breast cancer cells, a mechanism has been suggested in which resveratrol, when binding to an integrin located in the plasma membrane, triggers the activation of ERKs, which in turn phosphorylate p53 protein [57]. The gene discussed is TP53; the disease is breast cancer.